Work

Diterpenoid and Flavonol Glycosides from Sumatran Fern Selliguea feei Bory

Year: 2026
Type: article
Abstract: Selliguea feei Bory (Polypodiaceae) is a Sumatran fern whose rhizomes are traditionally used to treat rheumatism and hypertension. However, its fronds have not previously been chemically investigated, and none of its constituents have been evaluated against multidrug‑resistant bacteria. This study aimed to isolate and characterize secondary metabolites from the fronds of S. feei and to evaluate their antibacterial activity against clinical isolates of methicillin‑resistant Staphylococcus aureus (MRSA) and multidrug‑resistant Pseudomonas aeruginosa (MDRPA). Fresh fronds were macerated with methanol and successively partitioned with n‑hexane, ethyl acetate, and n‑butanol. The ethyl acetate and n‑butanol fractions were separated using silica gel column chromatography and crystallization. Structures were elucidated using 1D and 2D NMR, UV–Vis, IR, and LC–MS analyses. Antibacterial activity was determined using the agar diffusion method at 60 µg/disc, with chloramphenicol (3 µg/disc) as the positive control. Four known compounds were isolated: the diterpenoid onychiol B (1) and three flavonol glycosides, kaempferol‑7‑O‑α‑L‑rhamnoside (2), kaempferol‑3,7‑O‑α‑L‑dirhamnoside (3), and kaempferol‑3‑O‑β‑D‑glucoside‑7‑O‑α‑L‑rhamnoside (4). Compounds 1–3 are reported for the first time from the genus Selliguea. Compound 2 showed moderate inhibition of MRSA (12.17 ± 0.88 mm) and limited inhibition of MDRPA (6.92 ± 0.14 mm).
Language: English
Subfield: Plant Science
Open Access status: bronze
OpenAlex ID: W7235122471
FWCI:
Cites: 16
Cited by:
Related to: 10